@article{ajmcr2016415,
author={{John, Sabu and Kariyanna, Pramod Theetha and Marmur, Jonathan and Singh, Kamal Preet and Mallappallil, Mary},
title={A Case of Periprocedural Discontinuation of Apixaban Resulting in Intra-aortic Thrombosis},
journal={American Journal of Medical Case Reports},
volume={4},
number={1},
pages={16--18},
year={2016},
url={http://pubs.sciepub.com/ajmcr/4/1/5},
issn={2374-216X},
abstract={Apixaban, a novel oral anticoagulant is approved for anticoagulation in non-valvular atrial fibrillation. Apixaban is found to be superior to warfarin in prevention of stroke and thromboembolism and is associated with lesser risk of bleeding. Peri-procedural discontinuation of apixaban is safe, but the risk of thrombosis exists. We here present a case of arterial thrombosis that lead to lower limb ischemia upon periprocedural discontinuation of apixaban.},
doi={10.12691/ajmcr-4-1-5}
publisher={Science and Education Publishing}
}
